Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs Oscar Health Inc (OSCR) Price & Performance

iShares JPMorgan USD Emerging Markets Bond ETFTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

iShares JPMorgan USD Emerging Markets Bond ETF vs Oscar Health Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.02, while Oscar Health Inc trades at $28.58 (market cap $8.63B). The key difference: Oscar Health Inc is trading nearer its 52-week high, iShares JPMorgan USD Emerging Markets Bond ETF nearer its low. Which is the better fit depends on your goals.

EMBOSCR
Sector
Fixed IncomeHealth
52-Week High
$97.74$32.18
52-Week Low
$92.95$10.85
Market Cap
$8.63B
Enterprise Value
$4.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares JPMorgan USD Emerging Markets Bond ETF

EMB trades at $94.99 with minimal daily movement (+0.16%), showing technical bearish signals from moving averages while oscillators remain neutral. The stock faces significant selling pressure with support and resistance clustered around $95. Recent corporate actions include scheduled dividend payments through mid-2026, though key financial ratios remain undisclosed in current filings.

The outlook remains cautious with technical indicators favoring sellers and limited fundamental data available. Investment opportunity centers on dividend income stream, while risks include emerging market sovereign default exposure and Federal Reserve policy sensitivity. Analyst sentiment suggests limited upside potential beyond current yield returns.

Oscar Health Inc

OSCR trades at $27.97, up 1.08% today, with a bearish technical signal but strong recent earnings beats in Q1 and Q2 2026. The company reported record profitability and raised its full-year outlook, driven by membership growth and cost controls. Key support lies at $26, with resistance at $28. Revenue surged 70% year-over-year in H1 2026 to $4.9 billion, per PYMNTS on August 6, 2026.

Outlook is positive due to robust growth and margin expansion, but risks include execution challenges and competitive pressures. Analysts have a consensus price target of $32.50, with 27% buy ratings. The stock offers value with a P/S of 0.53, though net income volatility remains a concern.

Returns comparison

Trailing returns across standard periods

About iShares JPMorgan USD Emerging Markets Bond ETF

EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.

Read more on EMB

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR